BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1129 related articles for article (PubMed ID: 22044434)

  • 41. Narrow band imaging for detecting residual/recurrent cancerous tissue during second transurethral resection of newly diagnosed non-muscle-invasive high-grade bladder cancer.
    Naselli A; Introini C; Bertolotto F; Spina B; Puppo P
    BJU Int; 2010 Jan; 105(2):208-11. PubMed ID: 19549255
    [TBL] [Abstract][Full Text] [Related]  

  • 42. EFFICACY OF DIFFERENT RESECTIONS ON NON-MUSCLE-INVASIVE BLADDER CANCER AND ANALYSIS OF THE OPTIMAL SURGICAL METHOD.
    Chen GF; Shi TP; Wang BJ; Wang XY; Zang Q
    J Biol Regul Homeost Agents; 2015; 29(2):465-70. PubMed ID: 26122238
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Implications of the COVID19 pandemic on the need and timing of second transurethral bladder tumour resection in high-grade non-muscle invasive bladder cancer.
    Vanneste M; van der Heij B; Christiaansen CE; Berendsen CL; Driessen EJM; Bruins HM
    World J Urol; 2023 Aug; 41(8):2173-2178. PubMed ID: 37328699
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tumor recurrence in prostatic urethra following simultaneous resection of bladder tumor and prostate: a comparative retrospective study.
    Jaidane M; Bouicha T; Slama A; Hmida W; Hidoussi A; Ben Sorba N; Mosbah F
    Urology; 2010 Jun; 75(6):1392-5. PubMed ID: 19781747
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
    Solsona E; Iborra I; Rubio J; Casanova J; Almenar S
    BJU Int; 2004 Dec; 94(9):1258-62. PubMed ID: 15610101
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection.
    Del Giudice F; Barchetti G; De Berardinis E; Pecoraro M; Salvo V; Simone G; Sciarra A; Leonardo C; Gallucci M; Catalano C; Catto JWF; Panebianco V
    Eur Urol; 2020 Jan; 77(1):101-109. PubMed ID: 31699526
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data.
    Burger M; Grossman HB; Droller M; Schmidbauer J; Hermann G; Drăgoescu O; Ray E; Fradet Y; Karl A; Burgués JP; Witjes JA; Stenzl A; Jichlinski P; Jocham D
    Eur Urol; 2013 Nov; 64(5):846-54. PubMed ID: 23602406
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical impact of detrusor muscle in en bloc resection for T1 bladder cancer.
    Yanagisawa T; Sato S; Hayashida Y; Okada Y; Fukuokaya W; Iwatani K; Matsukawa A; Shimoda M; Takahashi H; Kimura T; Shariat SF; Miki J
    Urol Oncol; 2023 Dec; 41(12):484.e7-484.e15. PubMed ID: 37714725
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Outpatient diagnostic of bladder tumours in flexible cystoscopes: evaluation of fluorescence-guided flexible cystoscopy and bladder biopsies.
    Hermann GG; Mogensen K; Toft BG; Glenthøj A; Pedersen HM
    Scand J Urol Nephrol; 2012 Feb; 46(1):31-6. PubMed ID: 22150596
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of surgical experience on recurrence and progression after transurethral resection of bladder tumour in non-muscle-invasive bladder cancer.
    Jancke G; Rosell J; Jahnson S
    Scand J Urol; 2014 Jun; 48(3):276-83. PubMed ID: 24286506
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recurrence-free survival after radical cystectomy of patients downstaged by transurethral resection.
    Nielsen ME; Bastian PJ; Palapattu GS; Trock BJ; Schoenberg MP; Chan T; Rogers CG
    Urology; 2007 Dec; 70(6):1091-5. PubMed ID: 18158024
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: is immediate cystectomy always necessary?
    Wo JY; Shipley WU; Dahl DM; Coen JJ; Heney NM; Kaufman DS; Zietman AL
    BJU Int; 2009 Jul; 104(2):179-83. PubMed ID: 19154448
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Accurate preoperative prediction of non-organ-confined bladder urothelial carcinoma at cystectomy.
    Green DA; Rink M; Hansen J; Cha EK; Robinson B; Tian Z; Chun FK; Tagawa S; Karakiewicz PI; Fisch M; Scherr DS; Shariat SF
    BJU Int; 2013 Mar; 111(3):404-11. PubMed ID: 22805163
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A randomized prospective trial to assess the impact of transurethral resection in narrow band imaging modality on non-muscle-invasive bladder cancer recurrence.
    Naselli A; Introini C; Timossi L; Spina B; Fontana V; Pezzi R; Germinale F; Bertolotto F; Puppo P
    Eur Urol; 2012 May; 61(5):908-13. PubMed ID: 22280855
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Surveillance guidelines based on recurrence patterns after radical cystectomy for bladder cancer: the Canadian Bladder Cancer Network experience.
    Yafi FA; Aprikian AG; Fradet Y; Chin JL; Izawa J; Rendon R; Estey E; Fairey A; Cagiannos I; Lacombe L; Lattouf JB; Bell D; Saad F; Drachenberg D; Kassouf W
    BJU Int; 2012 Nov; 110(9):1317-23. PubMed ID: 22500588
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diffusion-weighted magnetic resonance imaging in follow-up of superficial urinary bladder carcinoma after transurethral resection: initial experience.
    El-Assmy A; Abou-El-Ghar ME; Refaie HF; Mosbah A; El-Diasty T
    BJU Int; 2012 Dec; 110(11 Pt B):E622-7. PubMed ID: 22757606
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Surgical experience is predictive for bladder tumour resection quality.
    Bube SH; Brix R; Christensen MB; Thostrup M; Grimstrup S; Hansen RB; Dahl C; Konge L; Azawi N
    Scand J Urol; 2022; 56(5-6):391-396. PubMed ID: 36065477
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Superficial bladder tumours: recurrence and progression.
    Mansoor M; Ali S; Fasihuddin Q; Baloch MU
    J Coll Physicians Surg Pak; 2011 Mar; 21(3):157-60. PubMed ID: 21419022
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Blue vs white light for transurethral resection of non-muscle-invasive bladder cancer: an abridged Cochrane Review.
    Maisch P; Koziarz A; Vajgrt J; Narayan V; Kim MH; Dahm P
    BJU Int; 2022 Dec; 130(6):730-740. PubMed ID: 35238145
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Total or partial prostate sparing cystectomy for invasive bladder cancer: long-term implications on erectile function.
    Davila HH; Weber T; Burday D; Thurman S; Carrion R; Salup R; Lockhart JL
    BJU Int; 2007 Nov; 100(5):1026-9. PubMed ID: 17868423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.